This study will determine the feasibility of the novel Indocyanine Green (ICG) fluorescence localization technique with a Laser fluorescence thoracoscope system.
The primary objective of this study is to prove the validity and safety of our novel fluorescent localization method with utilized ICG and novel near infra-red fluorescence videoscope system.
Full Title of Study: “Feasibility of a Novel Minimally Invasive Technique for Localization of Pulmonary Nodules Using the Spy Thoracoscope System”
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: February 2016
- Other: ICG Localization with Spy thoracoscope localization
Arms, Groups and Cohorts
- Experimental: VATS wedge lung resection
Clinical Trial Outcome Measures
- Compare incidence of Adverse Events (AE) occurrence due to ICG injection with micro-coil placement versus overall AE occurrence for micro-coil placement alone.
- Time Frame: Within 4 hours of ICG injection
Participating in This Clinical Trial
- Any patient scheduled for a VATS wedge lung resection using CT guided micro-coil lung implantation for the localization of the lung lesion.
- Any patients with an allergy to iodine, shellfish, or cough mixture, betadine or other iodine contrast agents.
- Pregnant or potentially pregnant women.
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- University Health Network, Toronto
- Novadaq Technologies ULC, now a part of Stryker
- Provider of Information About this Clinical Study
- Overall Official(s)
- Kazuhiro Yasufuku, MD, Principal Investigator, University Health Network, Toronto
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.